What's new

Human medicines European public assessment report (EPAR): Seladelpar Gilead, Seladelpar lysine dihydrate, Status: Authorised

Human medicines European public assessment report (EPAR): Seladelpar Gilead, Seladelpar lysine dihydrate, Status: Authorised

Feb 25, 2025 - 14:11
 0
Human medicines European public assessment report (EPAR): Seladelpar Gilead, Seladelpar lysine dihydrate, Status: Authorised
Human medicines European public assessment report (EPAR): Seladelpar Gilead, Seladelpar lysine dihydrate, Status: Authorised
Read More

Tags:

Previous Article

‘Fear and uncertainty’: Biotech investors warn of impact from NIH research cuts

Next Article

Fara Homidi Beauty Secures Sandbridge Capital Funding

Related Posts

Mandatory use of ISO/ICH E2B(R3) individual case safety reporting in the EU: hands-on training course using the EudraVigilance system, Online, European Medicines Agency, Amsterdam, the Netherlands, from 12 May 2025 to 16 May 2025

Mandatory use of ISO/ICH E2B(R3) individual case safety...

Feb 14, 2025  0

EMEA-003507-PIP01-23

EMEA-003507-PIP01-23

Feb 13, 2025  0

Patients' and Consumers' Working Party

Patients' and Consumers' Working Party

Feb 14, 2025  0